Our purpose was to illustrate that the effects of plumbagin on alleviating phenotype changes and dysfunction in the leptin-stimulated LSEC were achieved via the decreased expression of ET-1, VEGF, LN, and type IV collagen, effectively alleviating the mechanism causative of hepatic fibrosis. Here, LEP is linked to Hepatic fibrosis.